One pain you can’t afford to live with

One pain you can’t afford to live with

If there ever was a pain you shouldn’t tough out, it’s the kind caused by PVD (peripheral vascular disease). PVD occurs when the great vessels that branch off from the abdominal aorta and make their way down to the toes become hardened. If you don’t nip the problem in the bud, it can lead to the amputation of part, if not all, of your leg.

PVD is characterized by pain, usually in the calf, when walking. You could also experience numbness or tingling in your toes, cold feet, and sores on your lower leg that just won’t go away. Fortunately, it’s a treatable condition–and the results are often dramatic.

Here’s what to do: Mainstream treatments often call for angioplasty (performed the same way as in the heart), an arterial prosthesis (a plastic tube to replace one of the larger arteries), or bypass surgery. But it may be possible to avoid these radical approaches by doing something that will probably surprise you: walking.

This simple solution can work wonders because it can open up new arteries to relieve the obstructed ones. Yes, it will hurt at first, but the best thing to do is to start with short distances and gradually increase the distance you walk. Your goal should be to get up to three miles per day.

Another simple step you can take on your own is to quit smoking. Smoking is blamed for many things, often without proof, but in the case of PVD, it is a strong contributing factor.

One of the best alternative treatments for PVD is chelation therapy. You can learn more about this treatment by contacting the American College for Advancement in Medicine: (800)532-3688,

Obviously I can’t talk about every single painful condition–or every potential way to stamp out pain–in this one issue. But if you take away just one thing from what I’ve told you today, it should be this: You don’t have to live your life in pain–you just have to know where to look to find a solution that actually works. And it usually isn’t one that puts profits in Big Pharma’s pockets.